IMR Press / EJGO / Volume 19 / Issue 5 / pii/1998216

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen

Show Less
1 The Oncology Clinic, Karol Marcinkowski University of Medical Sciences, Poznań, Poland
Eur. J. Gynaecol. Oncol. 1998, 19(5), 503–507;
Published: 10 October 1998

The aim of the study was TPS diagnostic value determination in the serum of women with breast cancer as compared with MCA and CA 15-3. The relationship between the serum concentration of these antigens and patient age, clinical stage, histological grade, presence of metastases to lymph nodes and histological type of neoplasm was evaluated. Studies were conducted on the sera of 139 women before surgical procedure aged 28 - 81, treated in the Clinic of Oncology, at Karol Marcinkowski University of Medical Sciences in Poznan. The TPS concentration was determined using the “BEKI Diagnostics” immunoenzymatic method, MCA- by the “Roche” test and CA 15-3 concentration was determined by the “Abbott” immunofluorescent test. The study showed significantly higher levels of TPS, CA 15-3 and MCA in women with cancer, compared with values in healthy women and women with mastopathy. The highest median of concentration and frequency of occurrence was obtained for TPS. A correlation between enhancement of TPS and CA 15-3 concentration with clinical stage was observed. A similar connection was noted in women with meta­stases to the lymph nodes. Serum MCA concentration results did not demonstrate the above effects. The study suggests, that in esti­mating the clinical condition of women with breast cancer, the simultaneous determination of TPS with CA 15-3 seems to be a more useful prognostic factor than TPS or CA 15-3 with MCA.

Breast cancer
Tumour markers
TPS: CA 15-3
Back to top